IL157669A0 - Nitrogen-based camptothecin derivatives - Google Patents
Nitrogen-based camptothecin derivativesInfo
- Publication number
- IL157669A0 IL157669A0 IL15766902A IL15766902A IL157669A0 IL 157669 A0 IL157669 A0 IL 157669A0 IL 15766902 A IL15766902 A IL 15766902A IL 15766902 A IL15766902 A IL 15766902A IL 157669 A0 IL157669 A0 IL 157669A0
- Authority
- IL
- Israel
- Prior art keywords
- nitrogen
- camptothecin derivatives
- camptothecin
- based camptothecin
- esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/797,765 US6403604B1 (en) | 2001-03-01 | 2001-03-01 | Nitrogen-based camptothecin derivatives |
PCT/US2002/003798 WO2002070525A2 (fr) | 2001-03-01 | 2002-02-06 | Derives de camptothecine azotes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157669A0 true IL157669A0 (en) | 2004-03-28 |
Family
ID=25171748
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15766902A IL157669A0 (en) | 2001-03-01 | 2002-02-06 | Nitrogen-based camptothecin derivatives |
IL157669A IL157669A (en) | 2001-03-01 | 2003-08-31 | Nitrogen-based camptothecin derivatives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL157669A IL157669A (en) | 2001-03-01 | 2003-08-31 | Nitrogen-based camptothecin derivatives |
Country Status (13)
Country | Link |
---|---|
US (2) | US6403604B1 (fr) |
EP (1) | EP1383772B1 (fr) |
JP (1) | JP4584538B2 (fr) |
KR (1) | KR100853141B1 (fr) |
CN (1) | CN1246323C (fr) |
AT (1) | ATE338047T1 (fr) |
CA (1) | CA2439787C (fr) |
DE (1) | DE60214359T2 (fr) |
ES (1) | ES2274020T3 (fr) |
IL (2) | IL157669A0 (fr) |
MX (1) | MXPA03007896A (fr) |
NZ (1) | NZ528115A (fr) |
WO (1) | WO2002070525A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150343A (en) * | 1993-06-30 | 2000-11-21 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
US6492380B1 (en) * | 1999-05-17 | 2002-12-10 | Queen's University At Kingston | Method of inhibiting neurotrophin-receptor binding |
US6350756B1 (en) | 2001-01-18 | 2002-02-26 | California Pacific Medical Center | Camptothecin derivatives |
US6403604B1 (en) * | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
US6855720B2 (en) * | 2001-03-01 | 2005-02-15 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
AU2003243380A1 (en) * | 2002-06-03 | 2003-12-19 | California Pacific Medical Center | Nitrogen-based homo-camptothecin derivatives |
AU2003243397A1 (en) * | 2002-06-03 | 2003-12-19 | California Pacific Medical Center | Homo-camptothecin derivatives |
FR2889528B1 (fr) * | 2005-08-05 | 2007-09-07 | Servier Lab | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2889527A1 (fr) * | 2005-08-05 | 2007-02-09 | Servier Lab | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
KR20080058403A (ko) | 2005-09-15 | 2008-06-25 | 페인셉터 파마 코포레이션 | 뉴로트로핀 매개 활성 조절 방법 |
US7875602B2 (en) * | 2005-10-21 | 2011-01-25 | Sutter West Bay Hospitals | Camptothecin derivatives as chemoradiosensitizing agents |
CN100586952C (zh) * | 2006-11-10 | 2010-02-03 | 中国药科大学 | 噁唑骈喜树碱酯衍生物及其制备方法和用途 |
WO2009089537A2 (fr) | 2008-01-11 | 2009-07-16 | Northwestern University | Composés anticancéreux |
CN104622809B (zh) * | 2008-05-23 | 2019-04-19 | 英属哥伦比亚大学 | 用于脂质体纳米颗粒的修饰的药物 |
WO2010148138A2 (fr) * | 2009-06-17 | 2010-12-23 | Threshold Pharmaceuticals, Inc. | Dérivés de camptothécine |
US10391056B2 (en) | 2011-11-03 | 2019-08-27 | Taiwan Lipsome Company, LTD. | Pharmaceutical compositions of hydrophobic camptothecin derivatives |
US10980798B2 (en) | 2011-11-03 | 2021-04-20 | Taiwan Liposome Company, Ltd. | Pharmaceutical compositions of hydrophobic camptothecin derivatives |
CN109575044A (zh) * | 2018-12-21 | 2019-04-05 | 西安交通大学 | 2-(喜树碱-10-氧基)乙酰胺类化合物和应用 |
EP4176904A1 (fr) * | 2019-03-29 | 2023-05-10 | MedImmune Limited | Composés et leurs conjugués |
WO2021173773A1 (fr) | 2020-02-25 | 2021-09-02 | Mediboston, Inc. | Dérivés de camptothécine et leurs utilisations |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4943579A (en) | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
GB9320781D0 (en) | 1993-10-08 | 1993-12-01 | Erba Carlo Spa | Polymer-bound camptothecin derivatives |
US5965566A (en) | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5646159A (en) | 1994-07-20 | 1997-07-08 | Research Triangle Institute | Water-soluble esters of camptothecin compounds |
GB9504065D0 (en) | 1995-03-01 | 1995-04-19 | Pharmacia Spa | Poly-pyrrolecarboxamidonaphthalenic acid derivatives |
JPH08333370A (ja) * | 1995-06-08 | 1996-12-17 | Kyorin Pharmaceut Co Ltd | 水に可溶な新規フルオロエチルカンプトテシン誘導体、及びその製造方法 |
US6339091B1 (en) | 1995-06-21 | 2002-01-15 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Comptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
AU7732996A (en) | 1995-11-22 | 1997-06-11 | Research Triangle Institute | Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties |
US6096336A (en) | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
US5731316A (en) | 1996-01-30 | 1998-03-24 | The Stehlin Foundation For Cancer Research | Derivatives of camptothecin and methods of treating cancer using these derivatives |
CN1107678C (zh) | 1996-08-19 | 2003-05-07 | 比奥纽默里克药物公司 | 高亲脂性喜树碱衍生物,其制备方法及其用途 |
AU739028B2 (en) | 1996-09-27 | 2001-10-04 | Bristol-Myers Squibb Company | Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
ATE210673T1 (de) | 1996-09-30 | 2001-12-15 | Bayer Ag | Glycokonjugate von modifizierten camptothecin- derivaten (20-o-verknüpfung) |
SG104284A1 (en) | 1996-10-30 | 2004-06-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
UA57757C2 (uk) | 1996-12-20 | 2003-07-15 | Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) | Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція |
ID23424A (id) | 1997-05-14 | 2000-04-20 | Bayer Ag | Glikokonjugat dari 20(s)-kamptotesin |
GB9721070D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Bioactive derivatives of camptothecin |
US6153655A (en) | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
US6057303A (en) | 1998-10-20 | 2000-05-02 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic Camptothecin derivatives |
US6207832B1 (en) | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
WO2000066127A1 (fr) | 1999-05-04 | 2000-11-09 | Bionumerik Pharmaceuticals, Inc. | Nouveaux analogues de la camptothecine fortement liphophiles |
US6765019B1 (en) | 1999-05-06 | 2004-07-20 | University Of Kentucky Research Foundation | Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
US6288072B1 (en) * | 1999-12-29 | 2001-09-11 | Monroe E. Wall | Camptothecin β-alanine esters with topoisomerase I inhibition |
US6350756B1 (en) | 2001-01-18 | 2002-02-26 | California Pacific Medical Center | Camptothecin derivatives |
US6403604B1 (en) | 2001-03-01 | 2002-06-11 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
GB0119578D0 (en) | 2001-08-10 | 2001-10-03 | Pharmacia & Upjohn Spa | Fluoro linkers |
-
2001
- 2001-03-01 US US09/797,765 patent/US6403604B1/en not_active Expired - Lifetime
-
2002
- 2002-02-06 NZ NZ528115A patent/NZ528115A/en not_active IP Right Cessation
- 2002-02-06 MX MXPA03007896A patent/MXPA03007896A/es active IP Right Grant
- 2002-02-06 AT AT02718930T patent/ATE338047T1/de not_active IP Right Cessation
- 2002-02-06 DE DE60214359T patent/DE60214359T2/de not_active Expired - Lifetime
- 2002-02-06 IL IL15766902A patent/IL157669A0/xx unknown
- 2002-02-06 ES ES02718930T patent/ES2274020T3/es not_active Expired - Lifetime
- 2002-02-06 WO PCT/US2002/003798 patent/WO2002070525A2/fr active IP Right Grant
- 2002-02-06 KR KR1020037011466A patent/KR100853141B1/ko not_active IP Right Cessation
- 2002-02-06 EP EP02718930A patent/EP1383772B1/fr not_active Expired - Lifetime
- 2002-02-06 CN CNB028090543A patent/CN1246323C/zh not_active Expired - Fee Related
- 2002-02-06 JP JP2002569845A patent/JP4584538B2/ja not_active Expired - Fee Related
- 2002-02-06 CA CA2439787A patent/CA2439787C/fr not_active Expired - Fee Related
- 2002-05-23 US US10/154,768 patent/US6825207B2/en not_active Expired - Fee Related
-
2003
- 2003-08-31 IL IL157669A patent/IL157669A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4584538B2 (ja) | 2010-11-24 |
KR100853141B1 (ko) | 2008-08-20 |
US20030073698A1 (en) | 2003-04-17 |
JP2004529114A (ja) | 2004-09-24 |
US6403604B1 (en) | 2002-06-11 |
EP1383772A2 (fr) | 2004-01-28 |
ES2274020T3 (es) | 2007-05-16 |
MXPA03007896A (es) | 2004-06-07 |
CA2439787A1 (fr) | 2002-09-12 |
DE60214359T2 (de) | 2007-08-30 |
ATE338047T1 (de) | 2006-09-15 |
CN1511159A (zh) | 2004-07-07 |
NZ528115A (en) | 2006-04-28 |
WO2002070525A3 (fr) | 2003-02-20 |
CA2439787C (fr) | 2011-05-24 |
EP1383772B1 (fr) | 2006-08-30 |
CN1246323C (zh) | 2006-03-22 |
KR20040002872A (ko) | 2004-01-07 |
DE60214359D1 (en) | 2006-10-12 |
IL157669A (en) | 2010-11-30 |
US6825207B2 (en) | 2004-11-30 |
WO2002070525A2 (fr) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL157669A0 (en) | Nitrogen-based camptothecin derivatives | |
IL156967A0 (en) | Camptothecin derivatives | |
ZA200005098B (en) | Method for stabilizing pharmaceutical compositions by special use of an antioxidant. | |
PL367682A1 (en) | Dolastatin 10 derivatives | |
PL343495A1 (en) | Heterocyclically substituted amides used as calpain inhibitors | |
PL304649A1 (en) | Novel derivatives of taxane and pharmaceutical agents | |
WO2004043954A3 (fr) | Trans-9,10-dehydroepothilones c et d, leurs analogues et leurs procedes de production | |
CY2538B1 (en) | Tetrahydropyrido compounds | |
IL160437A0 (en) | INDENO [1,2-c] ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
HUP0402291A2 (hu) | Stabilizált azithromycin összetételek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
DE69938192D1 (en) | Imidazonaphthyridine | |
ATE260282T1 (de) | Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen | |
MXPA04003755A (es) | Endoprotesis vasculares. | |
GB9907571D0 (en) | Compounds | |
ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
AU2002218337A1 (en) | Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives | |
MY125674A (en) | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis | |
NO943765L (no) | Aryloksybenzen-herbicidmidler | |
MXPA03010737A (es) | Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion. | |
EP1436279B8 (fr) | Composes chimiques | |
HK1082727A1 (en) | 2" oxo-voruscharin and derivatives thereof | |
ES2103237A1 (es) | Nuevo compuesto derivado del cromeno | |
ZA200400824B (en) | Pyridin-2-yl-methlyamine derivatives for treating opioid dependence. | |
NZ505085A (en) | Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi |